Long-term Safety and Efficacy of Latanoprostene Bunod 0.024% in Japanese Subjects with Open-Angle Glaucoma or Ocular Hypertension: The JUPITER Study

Por Kawase, Kazuhide, Vittitow, Jason L., Weinreb, Robert N., Araie, Makoto
Publicado no Adv Ther (2016)

Latrunculin B Reduces Intraocular Pressure in Human Ocular Hypertension and Primary Open-Angle Glaucoma

Por Rasmussen, Carol A., Kaufman, Paul L., Ritch, Robert, Haque, Reza, Brazzell, R. Kim, Vittitow, Jason L.
Publicado em 2014

A randomised, controlled comparison of latanoprostene bunod and latanoprost 0.005% in the treatment of ocular hypertension and open angle glaucoma: the VOYAGER study

Por Weinreb, Robert N, Ong, Tuyen, Scassellati Sforzolini, Baldo, Vittitow, Jason L, Singh, Kuldev, Kaufman, Paul L
Publicado no Br J Ophthalmol (2015)